Tango Therapeutics: Q3 Earnings Insights

Tango Therapeutics TNGX reported its Q3 earnings results on Wednesday, November 8, 2023 at 07:00 AM.

Here's what investors need to know about the announcement.

Tango Therapeutics beat estimated earnings by 32.35%, reporting an EPS of $-0.23 versus an estimate of $-0.34.

Revenue was up $3.81 million from the same period last year.

Last quarter the company beat on EPS by $0.11 which was followed by a 11.34% increase in the share price the next day.

Here's a look at Tango Therapeutics's past performance:

Quarter	Q2 2023	Q1 2023	Q4 2022	Q3 2022
EPS Estimate	-0.34	-0.35	-0.35	-0.32
EPS Actual	-0.23	-0.32	-0.33	-0.33
Revenue Estimate	6.95M	6.71M	6.44M	5.53M
Revenue Actual	14.60M	5.77M	6.41M	6.92M

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Tango Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar